Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update on autologous hematopoietic stem cell transplantation for early-onset Type 1 Diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED